Evidence map›Paper›PMID 41896944›Full record

ArticleCell communication and signaling : CCS2026

Stabilization of cyclin D3 protein by CDKN1A (p21

Mohammed Ala Ghrib, Guy W Dayhoff, Cherif Chahtour, Carine Rodrigues-Machado, Abdelrahaman Youssef, Giorgio Schillaci, Guillaume Gautreau, Céline Henry, Vladimir N Uversky, Pascal Rigolet and 2 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mohammed Ala Ghrib *Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, F- 78350, France.
Guy W Dayhoff *Department of Chemistry, University of South Florida, Tampa, FL, 33620, USA.
Cherif Chahtour *Université Paris-Saclay, INRAE, MGP, Jouy-en-Josas, F-78350, France.
Carine Rodrigues-Machado *Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, F- 78350, France.
Abdelrahaman Youssef *Université Paris-Saclay, INRAE, MGP, Jouy-en-Josas, F-78350, France.
Giorgio SchillaciDepartment of Molecular Biosciences, University of South Florida, Tampa, FL, 33620, USA.
Guillaume GautreauUniversité Paris-Saclay, INRAE, MGP, Jouy-en-Josas, F-78350, France.
Céline HenryUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, F- 78350, France.
Vladimir N UverskyDepartment of Molecular Medicine, and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, 33620, USA.
Pascal RigoletUniversité Paris-Saclay, Orsay, 91405, France.
Hervé M BlottièreUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, F- 78350, France.
Jean-Marc LelièvreUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, F- 78350, France. jean-marc.lelievre@inrae.fr.ORCID http://orcid.org/0000-0003-0856-978X

Funding

French Embassy in Cairo, Arab Republic of Egypt M2 fellowshipInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement M2 FellowshipNational Science Foundation Graduate Research Fellowship Program NSF-1746051S.I.M., Algeria Fellowship
6 · The paper itself

Abstract

Butyrate-mediated inhibition of cell proliferation is part of the preventive role of dietary fiber against colorectal cancer (CRC). This effect notably involves the cyclin-dependent kinase inhibitor CDKN1A (p21Cip/Waf1) in human intestinal cells, yet the underlying molecular mechanisms remain incompletely understood. Previously, we observed a paradoxical increase in cyclin D3 (CCND3)—but not cyclin D1—levels upon butyrate exposure. Here, we demonstrate that the butyrate-induced accumulation of CCND3 protein results both from mRNA increase and a CDKN1A-dependent protein stabilization, specifically extending its nuclear half-life. Proteomic analyses of CCND3 co-immunoprecipitates identified complexes particularly enriched in butyrate-treated cells and involving CDKN1A, CDK4, CDK6, and the CRC-associated kinase CDK5. Phosphorylation at a conserved Thr residue in the C-terminal intrinsically disordered region, crucial for CCND nuclear export and subsequent proteasomal degradation, was notably reduced following butyrate treatment and inversely correlated with CDKN1A expression levels. Structural modeling based on AlphaFold2, complemented by molecular dynamics simulations, revealed possible differential interactions between CDKN1A and cyclins D1 and D3, predicting that CCND3-Thr283 becomes structurally buried upon CDKN1A binding, limiting its phosphorylation. Our findings suggest novel mechanistic insights into how the droplet driver CDKN1A might regulate CCND3 stability, highlighting previously unexplored roles of cyclin D3-containing complexes in cell cycle arrest induced by butyrate.

Indexed as

ButyratesCyclin D3Cyclin-Dependent Kinase Inhibitor p21HumansMolecular Dynamics SimulationPhosphorylationProtein StabilityButyratesCDKN1A protein, humanCyclin D3Cyclin-Dependent Kinase Inhibitor p21ButyrateCyclin DIntrinsically disordered protein structurePhosphorylationProtein interactions

Identifiers

PMID41896944
PMCPMC13151386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.